Skip to content
Riskpilot
← Back to search
Sign in
Get full access
GlioPharma ApS
APS
Dissolved
Advertising protection
CVR 37256641
Birkemose Allé 27, 6000
Kolding
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
·
NACE 721900
Est. 2015 · 10 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
/
GlioPharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2017
0M
0%
2018
Income statement
DKK thousands
Item
2017
2018
Gross profit
12
-15
Staff expenses
-0
-0
EBITDA
12
-15
Depreciation & amort.
-0
-0
EBIT
12
-15
Net financials
-5
-7
Profit before tax
7
-22
Tax
3
-0
Net profit
4
-22
Balance sheet
DKK thousands
Item
2017
2018
Total assets
184
169
Equity
54
33
Long-term debt
104
0
Short-term debt
26
136
Total debt
130
136
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1450500.0%
This company
2017
2018
Equity ratio
19.5%
This company
38.2%
Market median
-49% vs market
2017
2018
Return on equity
-65.8%
This company
18.4%
Market median
-458% vs market
2017
2018
Net profit margin (of gross profit)
-2160000.0%
This company
2017
2018
Asset turnover (of gross profit)
-0.09×
This company
2017
2018
Debt / equity
4.14×
This company
0.62×
Market median
-568% vs market
2017
2018
Annual reports & filings
Annual report 2018
Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2015-11-25 – 2017-04-30
View
PDF
More on GlioPharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
